We serve Chemical Name:sodium erythorbate monohydrate CAS:63524-04-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:sodium erythorbate monohydrate
CAS.NO:63524-04-9
Synonyms:EINECS 228-973-9;MFCD03788863;sodium,(2R)-2-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate,hydrate
Molecular Formula:C6H9NaO7
Molecular Weight:216.12100
HS Code:2932209090
Physical and Chemical Properties:
Melting point:165ºC (dec.)(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:119.28000
Exact Mass:216.02500
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like EINECS 228-973-9 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,sodium,(2R)-2-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate,hydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 228-973-9 Use and application,MFCD03788863 technical grade,usp/ep/jp grade.
Related News: Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other. N-ethyl-2-pyrazol-1-ylethanamine manufacturers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 1-[[2-(1,3-benzodioxol-5-yl)imidazo[1,2-a]pyrimidin-3-yl]methyl]piperidine-3-carboxylic acid suppliers Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other. 1-chloro-3-[(3-chlorophenyl)sulfonylmethylsulfonyl]benzene vendor & factory Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. ,The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics.
